Global Optic Nerve Disorders Treatment Market Size study & Forecast, by Treatment Type, by Indication, by End-User and Regional Analysis, 2022-2029

Description

List of Tables

Global Optic Nerve Disorders Treatment Market is valued at approximately USD 3.4 billion in 2021 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2022-2029. Optic Nerve Disorders can be defined as patterns of vision loss that are generally caused by developmental disorders or acquired disorders. Moreover, damage to an optic nerve or its pathways to the brain causes, loss of vision. There are different types of disorders that affect the optic nerve, including Coloboma of optic nerve, Glaucoma, Idiopathic intracranial hypertension, Neuromyelitis optica, Optic nerve atrophy, Optic nerve drusen, Optic nerve pit, Optic neuritis, Septo-optic dysplasia, and Toxic amblyopia (nutritional amblyopia) among others. The increasing incidence of glaucoma and growing number of aging populations are key factors driving the market growth.

The rising number of geriatric individuals is contributing towards the growth of the Global Optic Nerve Disorders Treatment Market. According to the World Bank Group, the world's old population was 727 million in 2020, and it is predicted to treble over the next three decades, reaching 1.5 billion in 2050. Another important component driving space is growing incidences of glaucoma. For instance - World Glaucoma Association - in 2020, globally around 79.6 million individuals were affected by glaucoma in 2020, and as per projections, this number is likely to increase to 111.8 million individuals in 2040. Also, growing expansion of pharmaceutical and biotechnology industries and rising healthcare spending would create a lucrative growth prospectus for the market over the forecast period. However, the high cost of Optic Nerve Disorders Treatment stifles market growth throughout the forecast period of 2022-2029.

The key regions considered for the Global Optic Nerve Disorders Treatment Market study include Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America dominated the market in terms of revenue, owing to factors such as increase in healthcare spending by the governments of nations in these regions and rise in awareness about optic nerve disorders. Whereas Asia Pacific is expected to grow with the highest CAGR during the forecast period, owing to factors such as rising geriatric and target populations, and presence of leading market players in the region.

Major market players included in this report are:

Santen Pharmaceutical Co. Limited
Allergan Plc.
Novartis AG
Pfizer, Inc.
Bausch Health Companies, Inc.
Aerie Pharmaceuticals, Inc.
Teva Pharmaceutical Industries Ltd.,
Bionure Farma, S.L.
Mallinckrodt Pharmaceuticals
AdvaCarePharma

Recent Developments in the Market:

In August 2020, The FDA approved Enspryng (satralizumab-mwge) for the treatment of neuromyelitis optica spectrum disorder (NMOSD) in adults. NMOSD is a rare autoimmune disease of the central nervous system that mainly affects the optic nerves and spinal cord.

Global Optic Nerve Disorders Treatment Market Report Scope:

Historical Data: 2019-2020-2021

Base Year for Estimation: 2021

Forecast period: 2022-2029

Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends

Segments Covered: Treatment Type, Indication, End-User, Region

Regional Scope: North America; Europe; Asia Pacific; Latin America; Rest of the World

Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below.

By Treatment Type

Pharmacological
Surgery

By Indication

Optic Neuritis
Glaucoma
Congenital Optic Atrophy
Optic Neuropathy
Others

By End-User

Hospitals
Clinics
Ambulatory Surgery Centers
Others

By Region:

North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
RoLA
Rest of the World

Chapter 1. Executive Summary

1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
- 1.2.1. Optic Nerve Disorders Treatment Market, by Region, 2019-2029 (USD Billion)
- 1.2.2. Optic Nerve Disorders Treatment Market, by Treatment Type, 2019-2029 (USD Billion)
- 1.2.3. Optic Nerve Disorders Treatment Market, by Indication, 2019-2029 (USD Billion)
- 1.2.4. Optic Nerve Disorders Treatment Market, by End-User, 2019-2029 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption

Chapter 2. Global Optic Nerve Disorders Treatment Market Definition and Scope

2.1. Objective of the Study
2.2. Market Definition & Scope
- 2.2.1. Scope of the Study
- 2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates

Chapter 3. Global Optic Nerve Disorders Treatment Market Dynamics

3.1. Optic Nerve Disorders Treatment Market Impact Analysis (2019-2029)
- 3.1.1. Market Drivers
  - 3.1.1.1. Increasing incidence of glaucoma
  - 3.1.1.2. Growing number of aging populations
- 3.1.2. Market Challenges
  - 3.1.2.1. High cost associated with optic nerve disorders treatment
- 3.1.3. Market Opportunities
  - 3.1.3.1. Growing expansion of pharmaceutical and biotechnology industries
  - 3.1.3.2. Rising healthcare spending

Chapter 4. Global Optic Nerve Disorders Treatment Market Industry Analysis

4.1. Porter's 5 Force Model
- 4.1.1. Bargaining Power of Suppliers
- 4.1.2. Bargaining Power of Buyers
- 4.1.3. Threat of New Entrants
- 4.1.4. Threat of Substitutes
- 4.1.5. Competitive Rivalry
4.2. Futuristic Approach to Porter's 5 Force Model (2019-2029)
4.3. PEST Analysis
- 4.3.1. Political
- 4.3.2. Economical
- 4.3.3. Social
- 4.3.4. Technological
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. Industry Experts Prospective
4.7. Analyst Recommendation & Conclusion

Chapter 5. Risk Assessment: COVID-19 Impact

5.1. Assessment of the overall impact of COVID-19 on the industry
5.2. Pre COVID-19 and post COVID-19 Market scenario

Chapter 6. Global Optic Nerve Disorders Treatment Market, by Treatment Type

6.1. Market Snapshot
6.2. Global Optic Nerve Disorders Treatment Market by Treatment Type, Performance - Potential Analysis
6.3. Global Optic Nerve Disorders Treatment Market Estimates & Forecasts by Treatment Type 2019-2029 (USD Billion)
6.4. Optic Nerve Disorders Treatment Market, Sub Segment Analysis
- 6.4.1. Pharmacological Treatment
- 6.4.2. Surgery

Chapter 7. Global Optic Nerve Disorders Treatment Market, by Indication

7.1. Market Snapshot
7.2. Global Optic Nerve Disorders Treatment Market by Indication, Performance - Potential Analysis
7.3. Global Optic Nerve Disorders Treatment Market Estimates & Forecasts by Indication 2019-2029 (USD Billion)
7.4. Optic Nerve Disorders Treatment Market, Sub Segment Analysis
- 7.4.1. Optic Neuritis
- 7.4.2. Glaucoma
- 7.4.3. Congenital Optic Atrophy
- 7.4.4. Optic Neuropathy
- 7.4.5. Others

Chapter 8. Global Optic Nerve Disorders Treatment Market, by End-User

8.1. Market Snapshot
8.2. Global Optic Nerve Disorders Treatment Market by End-User, Performance - Potential Analysis
8.3. Global Optic Nerve Disorders Treatment Market Estimates & Forecasts by End-User 2019-2029 (USD Billion)
8.4. Optic Nerve Disorders Treatment Market, Sub Segment Analysis
- 8.4.1. Hospitals
- 8.4.2. Clinics
- 8.4.3. Ambulatory Surgery Centers
- 8.4.4. Others

Chapter 9. Global Optic Nerve Disorders Treatment Market, Regional Analysis

9.1. Optic Nerve Disorders Treatment Market, Regional Market Snapshot
9.2. North America Optic Nerve Disorders Treatment Market
- 9.2.1. U.S. Optic Nerve Disorders Treatment Market
  - 9.2.1.1. Treatment Type breakdown estimates & forecasts, 2019-2029
  - 9.2.1.2. Indication breakdown estimates & forecasts, 2019-2029
  - 9.2.1.3. End-User breakdown estimates & forecasts, 2019-2029
- 9.2.2. Canada Optic Nerve Disorders Treatment Market
9.3. Europe Optic Nerve Disorders Treatment Market Snapshot
- 9.3.1. U.K. Optic Nerve Disorders Treatment Market
- 9.3.2. Germany Optic Nerve Disorders Treatment Market
- 9.3.3. France Optic Nerve Disorders Treatment Market
- 9.3.4. Spain Optic Nerve Disorders Treatment Market
- 9.3.5. Italy Optic Nerve Disorders Treatment Market
- 9.3.6. Rest of Europe Optic Nerve Disorders Treatment Market
9.4. Asia-Pacific Optic Nerve Disorders Treatment Market Snapshot
- 9.4.1. China Optic Nerve Disorders Treatment Market
- 9.4.2. India Optic Nerve Disorders Treatment Market
- 9.4.3. Japan Optic Nerve Disorders Treatment Market
- 9.4.4. Australia Optic Nerve Disorders Treatment Market
- 9.4.5. South Korea Optic Nerve Disorders Treatment Market
- 9.4.6. Rest of Asia Pacific Optic Nerve Disorders Treatment Market
9.5. Latin America Optic Nerve Disorders Treatment Market Snapshot
- 9.5.1. Brazil Optic Nerve Disorders Treatment Market
- 9.5.2. Mexico Optic Nerve Disorders Treatment Market
- 9.5.3. Rest of Latin America Optic Nerve Disorders Treatment Market
9.6. Rest of The World Optic Nerve Disorders Treatment Market

Chapter 10. Competitive Intelligence

10.1. Top Market Strategies
10.2. Company Profiles
- 10.2.1. Santen Pharmaceuticals Co. Limited
  - 10.2.1.1. Key Information
  - 10.2.1.2. Overview
  - 10.2.1.3. Financial (Subject to Data Availability)
  - 10.2.1.4. Product Summary
  - 10.2.1.5. Recent Developments
- 10.2.2. Allergan Plc.
- 10.2.3. Novartis AG
- 10.2.4. Pfizer, Inc.
- 10.2.5. Bausch Health Companies, Inc.
- 10.2.6. Aerie Pharmaceuticals, Inc.
- 10.2.7. Teva Pharmaceutical Industries Ltd.,
- 10.2.8. Bionure Farma, S.L.
- 10.2.9. Mallinckrodt Pharmaceuticals
- 10.2.10. AdvaCarePharma

Chapter 11. Research Process

11.1. Research Process
- 11.1.1. Data Mining
- 11.1.2. Analysis
- 11.1.3. Market Estimation
- 11.1.4. Validation
- 11.1.5. Publishing
11.2. Research Attributes
11.3. Research Assumption

LIST OF TABLES

TABLE 1. Global Optic Nerve Disorders Treatment Market, report scope
TABLE 2. Global Optic Nerve Disorders Treatment Market estimates & forecasts by Region 2019-2029 (USD Billion)
TABLE 3. Global Optic Nerve Disorders Treatment Market estimates & forecasts by Treatment Type 2019-2029 (USD Billion)
TABLE 4. Global Optic Nerve Disorders Treatment Market estimates & forecasts by Indication 2019-2029 (USD Billion)
TABLE 5. Global Optic Nerve Disorders Treatment Market estimates & forecasts by End-User 2019-2029 (USD Billion)
TABLE 6. Global Optic Nerve Disorders Treatment Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 7. Global Optic Nerve Disorders Treatment Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 8. Global Optic Nerve Disorders Treatment Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 9. Global Optic Nerve Disorders Treatment Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 10. Global Optic Nerve Disorders Treatment Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 11. Global Optic Nerve Disorders Treatment Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 12. Global Optic Nerve Disorders Treatment Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 13. Global Optic Nerve Disorders Treatment Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 14. Global Optic Nerve Disorders Treatment Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 15. Global Optic Nerve Disorders Treatment Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 16. U.S. Optic Nerve Disorders Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 17. U.S. Optic Nerve Disorders Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 18. U.S. Optic Nerve Disorders Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 19. Canada Optic Nerve Disorders Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 20. Canada Optic Nerve Disorders Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 21. Canada Optic Nerve Disorders Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 22. UK Optic Nerve Disorders Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 23. UK Optic Nerve Disorders Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 24. UK Optic Nerve Disorders Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 25. Germany Optic Nerve Disorders Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 26. Germany Optic Nerve Disorders Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 27. Germany Optic Nerve Disorders Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 28. France Optic Nerve Disorders Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 29. France Optic Nerve Disorders Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 30. France Optic Nerve Disorders Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 31. Italy Optic Nerve Disorders Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 32. Italy Optic Nerve Disorders Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 33. Italy Optic Nerve Disorders Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 34. Spain Optic Nerve Disorders Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 35. Spain Optic Nerve Disorders Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 36. Spain Optic Nerve Disorders Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 37. RoE Optic Nerve Disorders Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 38. RoE Optic Nerve Disorders Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 39. RoE Optic Nerve Disorders Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 40. China Optic Nerve Disorders Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 41. China Optic Nerve Disorders Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 42. China Optic Nerve Disorders Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 43. India Optic Nerve Disorders Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 44. India Optic Nerve Disorders Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 45. India Optic Nerve Disorders Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 46. Japan Optic Nerve Disorders Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 47. Japan Optic Nerve Disorders Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 48. Japan Optic Nerve Disorders Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 49. South Korea Optic Nerve Disorders Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 50. South Korea Optic Nerve Disorders Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 51. South Korea Optic Nerve Disorders Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 52. Australia Optic Nerve Disorders Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 53. Australia Optic Nerve Disorders Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 54. Australia Optic Nerve Disorders Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 55. RoAPAC Optic Nerve Disorders Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 56. RoAPAC Optic Nerve Disorders Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 57. RoAPAC Optic Nerve Disorders Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 58. Brazil Optic Nerve Disorders Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 59. Brazil Optic Nerve Disorders Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 60. Brazil Optic Nerve Disorders Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 61. Mexico Optic Nerve Disorders Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 62. Mexico Optic Nerve Disorders Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 63. Mexico Optic Nerve Disorders Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 64. RoLA Optic Nerve Disorders Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 65. RoLA Optic Nerve Disorders Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 66. RoLA Optic Nerve Disorders Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 67. Row Optic Nerve Disorders Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 68. Row Optic Nerve Disorders Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 69. Row Optic Nerve Disorders Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 70. List of secondary sources, used in the study of global Optic Nerve Disorders Treatment Market
TABLE 71. List of primary sources, used in the study of global Optic Nerve Disorders Treatment Market
TABLE 72. Years considered for the study
TABLE 73. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

List of figures

FIG 1. Global Optic Nerve Disorders Treatment Market, research methodology
FIG 2. Global Optic Nerve Disorders Treatment Market, Market estimation techniques
FIG 3. Global Market size estimates & forecast methods
FIG 4. Global Optic Nerve Disorders Treatment Market, key trends 2021
FIG 5. Global Optic Nerve Disorders Treatment Market, growth prospects 2022-2029
FIG 6. Global Optic Nerve Disorders Treatment Market, porters 5 force model
FIG 7. Global Optic Nerve Disorders Treatment Market, pest analysis
FIG 8. Global Optic Nerve Disorders Treatment Market, value chain analysis
FIG 9. Global Optic Nerve Disorders Treatment Market by segment, 2019 & 2029 (USD Billion)
FIG 10. Global Optic Nerve Disorders Treatment Market by segment, 2019 & 2029 (USD Billion)
FIG 11. Global Optic Nerve Disorders Treatment Market by segment, 2019 & 2029 (USD Billion)
FIG 12. Global Optic Nerve Disorders Treatment Market by segment, 2019 & 2029 (USD Billion)
FIG 13. Global Optic Nerve Disorders Treatment Market by segment, 2019 & 2029 (USD Billion)
FIG 14. Global Optic Nerve Disorders Treatment Market, regional snapshot 2019 & 2029
FIG 15. North America Optic Nerve Disorders Treatment Market 2019 & 2029 (USD Billion)
FIG 16. Europe Optic Nerve Disorders Treatment Market 2019 & 2029 (USD Billion)
FIG 17. Asia Pacific Optic Nerve Disorders Treatment Market 2019 & 2029 (USD Billion)
FIG 18. Latin America Optic Nerve Disorders Treatment Market 2019 & 2029 (USD Billion)
FIG 19. Global Optic Nerve Disorders Treatment Market, company Market share analysis (2021)